Press Releases
Date Title and Summary View
Feb 21, 2012 San Diego and New York (February 21, 2012) – Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Retrophin, LLC announced that the companies have entered into an agreement in which Ligand has licensed rights to DARA (a Dual Acting Receptor Antagonist of Angiotensin and Endothelin receptors) to R...
Page: FirstPrevious ...
15
= add release to Briefcase